Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rationale and Design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial

NCT04045093 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04045093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04045093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rationale and Design of Dabigatran for Mitral Stenosis Atrial Fibrillation Trial
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Active, not recruiting
Start date
October 22, 2020
Completion date
September 30, 2027
Enrollment
370 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, mitral stenosis